150 related articles for article (PubMed ID: 25824337)
1. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
[TBL] [Abstract][Full Text] [Related]
2. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
[TBL] [Abstract][Full Text] [Related]
3. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma.
Chen PT; Hsieh CC; Chen MF
Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989
[TBL] [Abstract][Full Text] [Related]
4. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
[TBL] [Abstract][Full Text] [Related]
5. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
[TBL] [Abstract][Full Text] [Related]
6. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
[TBL] [Abstract][Full Text] [Related]
7. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.
Qiao Y; Zhang C; Li A; Wang D; Luo Z; Ping Y; Zhou B; Liu S; Li H; Yue D; Zhang Z; Chen X; Shen Z; Lian J; Li Y; Wang S; Li F; Huang L; Wang L; Zhang B; Yu J; Qin Z; Zhang Y
Oncogene; 2018 Feb; 37(7):873-883. PubMed ID: 29059160
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
[TBL] [Abstract][Full Text] [Related]
10. Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells.
Li X; Chen D; Li M; Gao X; Shi G; Zhao H
Biomed Pharmacother; 2018 Jun; 102():1045-1051. PubMed ID: 29710521
[TBL] [Abstract][Full Text] [Related]
11. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
[TBL] [Abstract][Full Text] [Related]
13. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
[TBL] [Abstract][Full Text] [Related]
14. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment.
Chen MF; Chen PT; Lu MS; Chen WC
Mol Carcinog; 2018 Jan; 57(1):78-88. PubMed ID: 28888039
[TBL] [Abstract][Full Text] [Related]
15. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice.
Padi SK; Zhang Q; Rustum YM; Morrison C; Guo B
Gastroenterology; 2013 Aug; 145(2):437-46. PubMed ID: 23619147
[TBL] [Abstract][Full Text] [Related]
17. Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab.
Yamazaki M; Yamashita Y; Kubo N; Yashiro M; Ohira M; Ako E; Tanaka H; Muguruma K; Sawada T; Hirakawa K
Oncol Rep; 2012 Jul; 28(1):49-54. PubMed ID: 22562413
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma.
Chen MF; Lu MS; Hsieh CC; Chen WC
Cell Oncol (Dordr); 2021 Apr; 44(2):373-384. PubMed ID: 33201403
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]